EXC vs MGX · P/E 17, rev $24.26B vs rev $25.2M
Exelon Corporation (EXC) versus Metagenomi, Inc. Common Stock (MGX) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. MGX currently screens at market cap $44.4M.
Not investment advice. Open the EXC and MGX stock pages for the full models.
Not investment advice.